HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
The evolving landscape of metabolic health continues to highlight the critical role endocrinologists play in addressing obesity-related conditions. With a deep understanding of hormonal imbalances and metabolic dysfunction, endocrinologists are at the forefront of identifying underlying causes of weight gain, such as thyroid disorders, insulin resistance, and adrenal dysfunction. Their clinical insight contributes to more accurate diagnoses and tailored treatment plans that consider each patient’s endocrine profile. Focusing on obesity and metabolic health bring together experts from various disciplines, offering endocrinologists a platform to collaborate, share groundbreaking research, and explore innovative interventions that go beyond traditional weight-loss strategies. As obesity becomes an increasingly complex global health issue, endocrinologists are uniquely positioned to bridge the gap between clinical science and patient-centered care. Their expertise extends into prescribing and managing pharmacologic therapies, including GLP-1 receptor agonists and SGLT2 inhibitors, which have shown significant promise in weight and diabetes management. These gatherings provide an invaluable opportunity for endocrinologists to engage with peers in discussions around the latest treatment modalities, preventative strategies, and advances in technology, such as continuous glucose monitoring and metabolic profiling. Their involvement ensures a more holistic and hormonal-centric approach to combating obesity, emphasizing long-term management over short-term solutions.
